Skip to content

Clinical trials

Completed Precursor Cell Lymphoblastic Leukemia-Lymphoma trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Precursor Cell Lymphoblastic Leukemia-Lymphoma Status: Completed Country / region: Russia Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20091
20101
20121
20132
20141
20153
20161
20201
20213
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen3
St. Petersburg State Pavlov Medical University3
Bristol-Myers Squibb2
Institut de Recherches Internationales Servier2
Novartis Pharmaceuticals2
Amgen Research (Munich) GmbH1
GlaxoSmithKline1
Ivan S Moiseev1
National Research Center for Hematology, Russia1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Precursor Cell Lymphoblastic Leukemia-Lymphoma16
Leukemia, Myeloid, Acute4
Neoplasms4
Immune System Diseases2
Leukemia2
Leukemia, Biphenotypic, Acute2
Leukemia, Lymphocytic, Chronic, B-Cell2
Lymphoma2
Lymphoproliferative Disorders2
Myelodysplastic Syndromes2

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.